About Aspen Oss

Aspen Oss has a proud history in the production of APIs, spanning over 90 years.

Aspen Oss specializes in the manufacture of highly complex APIs.

We are dedicated to the production of high quality APIs and delivering extensive quality and regulatory support.

 Aspen Holding News

  • Aspen launches novel ARV Combination: Set to further improve treatment options
    Johannesburg: Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of EmdoltenTM, a Dolutegravir-based triple combination anti-retroviral (ARV) treatment option. EmdoltenTM, a once a day triple combination tablet therapy in the form of Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate, is positioned to become a preferred first line ARV and will…
  • Aspen’s participation in the 2018 Investment Conference
    Sandton – Aspen welcomes President Ramaphosa’s inaugural Investment Conference, aimed at positioning South Africa as a preferred investment destination and at establishing a more predictable and stable investment environment in our country. Amongst other initiatives, this includes facilitating the ease of doing business and reducing unnecessary regulatory burden in the South African pharmaceutical sector. These…
  • Aspen supports the World Thrombosis Day campaign
    Aspen remains committed to the World Thrombosis Day campaign to raise awareness of thrombosis as an urgent and growing public health problem. PARIS, FRANCE – Aspen has reinforced its commitment to fight thrombosis worldwide through its long-standing partnership with the International Society on Thrombosis and Haemostasis (ISTH) World Thrombosis Day (WTD) campaign. This initiative aims to…

News and Events Aspen Oss

Aspen werken bij Babet Hogervorst 7533web

Aspen Oss Downloads

Company brochure (pdf)

Product list (Z-Card) (pdf)

Highly Potent API development and manufacturing capabilities (pdf)

Peptide development and manufacturing capabilities (pdf)


Aspen Holding Results and Reports

Aspen reviewed provisional group financial results for the year ended 30 June 2018:

Aspen year end results commentary (PDF 234KB)

Aspen year end results presentation (PDF 2.7MB)

Aspen short form announcement (PDF 250KB)

Aspen Integrated Report 2017 (PDF 6 MB)

Aspen Corporate Brochure 2017 (PDF 3 MB)